news
Petrovax Group completed supplying A/H1N1 vaccines under first state contract
Petrovax Group initiates clinical studies of A/H1N1 flu virus vaccines on children
Petrovax Group launched production of vaccine targeting highly pathogenic influenza virus A/H1N1
Petrovax Group was issued MA’s for two influenza A/H1N1 vaccines
Petrovax Group receives MA for Grippol Neo, an innovative flu vaccine
Petrovax Group made first vaccine shipments for National Priority Health Project
Grippol Plus and Grippol vaccines supplied for Russian National Health Project
